Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells

The Role of Angiogenesis in Human Non-Hodgkin Lymphomas

(2015) Domenico Ribatti et al.   NEOPLASIA

Turning a water and oil insoluble cisplatin derivative into a nanoparticle formulation for cancer therapy

(2014) Shutao Guo et al.   BIOMATERIALS

Challenges and Key Considerations of the Enhanced Permeability and Retention Effect for Nanomedicine Drug Delivery in Oncology

(2013) U. Prabhakar et al.   CANCER RESEARCH

Adoptive T-Cell Therapy for Cancer: Boutique Therapy or Treatment Modality?

(2013) C. Yee   CLINICAL CANCER RESEARCH

Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38

(2013) Vaskor Bala et al.   JOURNAL OF CONTROLLED RELEASE

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia

(2013) Stephan A. Grupp et al.   NEW ENGLAND JOURNAL OF MEDICINE

Synthesis and Biological Response of Size-Specific, Monodisperse Drug–Silica Nanoconjugates

(2012) Li Tang et al.   ACS Nano

Biomimetic Delivery with Micro- and Nanoparticles

(2012) Stephen C. Balmert et al.   ADVANCED MATERIALS

Synapse-directed delivery of immunomodulators using T-cell-conjugated nanoparticles

(2012) Matthias T. Stephan et al.   BIOMATERIALS

Use of macrophages to deliver therapeutic and imaging contrast agents to tumors

(2012) Jinhyang Choi et al.   BIOMATERIALS

Mesenchymal stem cell-based cell engineering with multifunctional mesoporous silica nanoparticles for tumor delivery

(2012) Xinglu Huang et al.   BIOMATERIALS

Specific Lymphocyte Subsets Predict Response to Adoptive Cell Therapy Using Expanded Autologous Tumor-Infiltrating Lymphocytes in Metastatic Melanoma Patients

(2012) L. G. Radvanyi et al.   CLINICAL CANCER RESEARCH

T-cell therapy at the threshold

(2012) Carl June et al.   NATURE BIOTECHNOLOGY

Nanomaterials for Drug Delivery

(2012) J. A. Hubbell et al.   SCIENCE

Cooperative function of CCR7 and lymphotoxin in the formation of a lymphoma-permissive niche within murine secondary lymphoid organs

(2011) A. Rehm et al.   BLOOD

Cell-mediated drug delivery

(2011) Elena V Batrakova et al.   Expert Opinion on Drug Delivery

Potent Engineered PLGA Nanoparticles by Virtue of Exceptionally High Chemotherapeutic Loadings

(2011) Elizabeth M. Enlow et al.   NANO LETTERS

Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses

(2011) James J. Moon et al.   NATURE MATERIALS

Therapeutic cell engineering with surface-conjugated synthetic nanoparticles

(2010) Matthias T Stephan et al.   NATURE MEDICINE

Strategies in the design of nanoparticles for therapeutic applications

(2010) Robby A. Petros et al.   NATURE REVIEWS DRUG DISCOVERY

mTOR regulates memory CD8 T-cell differentiation

(2009) Koichi Araki et al.   NATURE

Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer

(2009) K. P. Olive et al.   SCIENCE

Utilization of Pathway Signatures to Reveal Distinct Types of B Lymphoma in the E -myc Model and Human Diffuse Large B-Cell Lymphoma

(2008) S. Mori et al.   CANCER RESEARCH

Cell vehicle targeting strategies

(2008) J C Roth et al.   GENE THERAPY

Potent antitumor effect of SN-38-incorporating polymeric micelle, NK012, against malignant glioma

(2008) Jun-ichiro Kuroda et al.   INTERNATIONAL JOURNAL OF CANCER

Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking

(2008) Linda V Sinclair et al.   NATURE IMMUNOLOGY

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY

Topoisomerase levels determine chemotherapy responsein vitroandin vivo

(2008) Darren J. Burgess et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Dose translation from animal to human studies revisited

(2007) Shannon Reagan-Shaw et al.   FASEB JOURNAL